Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 20,789 | 15,753 | 12,998 | 20,382 | 0 |
| Gross Profit | 20,789 | 15,753 | 12,998 | 20,382 | N/A |
| Operating Expenses | 46,302 | 37,564 | 23,490 | 21,382 | 19,698 |
| Operating Income | -25,513 | -21,811 | -10,492 | -1,000 | -19,698 |
| Interest Expense | 446 | -328 | 409 | 536 | -300 |
| Other Income | -32 | -302 | 0 | 0 | 0 |
| Pre-tax Income | -25,991 | -21,785 | -10,901 | -1,536 | -19,398 |
| Income Tax | N/A | N/A | 1 | 35 | 51 |
| Net Income Continuous | -25,991 | -21,785 | -10,902 | -1,571 | -19,449 |
| Net Income | $-25,991 | $-21,785 | $-10,902 | $-1,571 | $-19,449 |
| EPS Basic Total Ops | -2.15 | -2.16 | -3.53 | -0.77 | -6.30 |
| EPS Basic Continuous Ops | -2.15 | -2.16 | -3.53 | -0.77 | -6.29 |
| EPS Diluted Total Ops | -2.15 | -2.16 | -3.53 | -0.77 | -6.30 |
| EPS Diluted Continuous Ops | -2.15 | -2.16 | -3.53 | -0.77 | -6.29 |
| EPS Diluted Before Non-Recurring Items | -2.15 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-24,829 | $-21,229 | $-10,082 | $-706 | $-19,647 |